Search

Search Results
Results 1051 - 1060 of 1077 for Diabetes Type II
  • Drug - 2 May 2024
    Consumer Medicine Information (CMI) about Coveram intended for persons living in Australia.
  • Drug - 6 Mar 2024
    Consumer Medicine Information (CMI) about Erlyand intended for persons living in Australia.
  • Drug - 13 Feb 2024
    Consumer Medicine Information (CMI) about Trikafta intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Dicarz intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brooke (drospirenone 3 mg and ethinylestradiol 20 micrograms) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brooklynn (drospirenone 3 mg and ethinylestradiol 30 micrograms) intended for persons living in Australia.
  • Health - 11 Sep 2023
    ACE inhibitors work by interfering with the body's renin-angiotensin-aldosterone system (RAAS) and are used to treat a variety of diseases.
  • Health - 3 Jul 2023
    Diabetic coma is a condition that poses a dangerous threat to individuals with diabetes. Treatment is more effective the earlier it is started but depends on the cause of the coma as this defines...
  • Health - 23 Jun 2023
    There are several risk factors for cardiovascular diseases. Some of these are un-changeable. These include advancing age, male sex and women after menopause and genetic disposition to acquire heart...
  • Health - 21 Apr 2023
    Microvascular endothelial dysfunction is an early or inductive event that occurs in the development of cardiovascular diseases and associated organ damage.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.